TIDMBYOT
Byotrol PLC
26 February 2021
B y otrol Plc
( " B y o t rol" or the "Company")
Landmark test protocol for testing long-lasting anti-viral
efficacy
Byotrol plc (AIM:BYOT), the specialist infection prevention and
control company, is pleased to announce that it has developed and
externally validated a new test for determining whether cleaning
and sanitising products have long-lasting efficacy against viruses
in real-life use.
-- This new test determines whether sanitising and cleaning
products offer any long-lasting protection against COVID-19
-- Byotrol is now standing behind product efficacy claims
supporting infection control products that offer 24-hour protection
against viruses and bacteria in real-life conditions, where
surfaces are frequently touched
-- The Company believes that this new test could help minimise
the spread of the virus when used in conjunction with the cleaning
and sanitising of shops, schools and offices when they reopen
Byotrol has developed the new test in response to an increasing
number of products claiming long-lasting efficacy against
coronavirus, based on laboratory conditions which ignore the
constant abrasion of surfaces in real-life environments (and which
would then make many products ineffective).
Byotrol developed the industry standard test for long-lasting
efficacy in real-life against bacteria and yeast in 2014 with the
help of independent industry experts. The test, named PAS
2424:2014, was approved by the British Standards Institute (BSI)
and is the only British standard to prove the efficacy of a
disinfectant product over 24 hours. The PAS 2424:2014 test is
currently being reviewed by the CEN Committee for approval as a new
European EN test standard.
This new test for viruses simulates 'real-life' conditions by
creating frequent abrasions on surfaces after products have been
applied, to replicate frequent touching of surfaces throughout the
day. The surfaces are then tested to see whether the product is
still present and killing viruses. The test is limited to 24 hours,
to ensure that the result is attributed to the efficacy of the
product, not the length of time the virus has been left to dry out
on a surface, which could result in a false positive.
This new test was performed internally in Byotrol's virology lab
with the results being reviewed and validated externally by
Professor James Stewart, Chair of Molecular Virology at the
University of Liverpool, who commented: "A validation of the
effectiveness of surface disinfectants against viruses using this
test is an important step forward for the industry and consumers
alike."
Byotrol plans to gain approval from the BSI again, to make this
new test the British standard for proving the long-lasting efficacy
of disinfectants against viruses.
The application of this test could help businesses and consumers
select products which are proven to be effective in a variety of
public spaces where surfaces are frequently touched, genuinely
promoting public health.
Trevor Francis, Chief Technology Officer of Byotrol plc
commented :
"Long-term surface protection against viruses is the holy grail
that businesses in the hygiene sector are chasing currently. We
have responded to a clear market need for clarity on which surface
disinfectants continue to deactivate viruses in real-life
environments and which don't. It's a huge win for consumers and the
government as we return to normality beyond the pandemic."
Enquiries:
Byotrol plc
Trevor Francis - Chief Technology Officer
David Traynor - Chief Executive Officer
Nic Hellyer - Chief Financial Officer 01925 742 000
finnCap
Geoff Nash/Kate Bannatyne - Corporate Finance 020 7220 0500
Richard Chambers - ECM
Flagstaff Strategic and Investor Communications
Tim Thompson/Andrea Seymour/Fergus Mellon +44 (0)207 129 1474
byotrol@flagstaffcomms.com
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection
prevention and control company, operating globally in the
Healthcare, Industrial, Food and Consumer sectors, providing low
toxicity products with a broad-based and targeted efficacy across
all microbial classes; bacteria, viruses (including coronavirus),
fungi, moulds, mycobacteria and algae.
Byotrol's products can be used stand-alone or as ingredients
within existing products, where they can significantly improve
their performance, especially in personal hygiene, domestic and
industrial disinfection, odour control, food production and food
management.
Byotrol develops and commercialises technologies that create
easier, safer and cleaner lives for everyone.
For more information, please go to byotrol.co.uk
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRABLGDDIXDDGBU
(END) Dow Jones Newswires
February 26, 2021 02:00 ET (07:00 GMT)
Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Set 2023 a Set 2024